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During efforts to crystallize the enzyme 2,4-dihydroxyacetophenone dioxy-
genase (DAD) from Alcaligenes sp. 4HAP, a small number of strongly
diffracting protein crystals were obtained after two years of crystal growth in
one condition. The crystals diffracted synchrotron radiation to almost 1.0 A˚
resolution and were, until recently, assumed to be formed by the DAD protein.
However, when another crystal form of this enzyme was eventually solved at
lower resolution, molecular replacement using this new structure as the search
model did not give a convincing solution with the original atomic resolution data
set. Hence, it was considered that these crystals might have arisen from a protein
impurity, although molecular replacement using the structures of common
crystallization contaminants as search models again failed. A script to perform
molecular replacement using MOLREP in which the ﬁrst chain of every
structure in the PDB was used as a search model was run on a multi-core cluster.
This identiﬁed a number of prokaryotic phosphate-binding proteins as scoring
highly in the MOLREP peak lists. Calculation of an electron-density map at
1.1 A˚ resolution based on the solution obtained with PDB entry 2q9t allowed
most of the amino acids to be identiﬁed visually and built into the model. A
BLAST search then indicated that the molecule was most probably a phosphate-
binding protein from Stenotrophomonas maltophilia (UniProt ID B4SL31; gene
ID Smal_2208), and ﬁtting of the corresponding sequence to the atomic
resolution map fully corroborated this. Proteins in this family have been linked
to the virulence of antibiotic-resistant strains of pathogenic bacteria and with
bioﬁlm formation. The structure of the S. maltophilia protein has been reﬁned to
an R factor of 10.15% and an Rfree of 12.46% at 1.1 A˚ resolution. The molecule
adopts the type II periplasmic binding protein (PBP) fold with a number of
extensively elaborated loop regions. A fully dehydrated phosphate anion is
bound tightly between the two domains of the protein and interacts with
conserved residues and a number of helix dipoles.
1. Introduction
The widely occurring Gram-negative bacterium Steno-
trophomonas maltophilia is a relatively rare cause of human
disease, but it is known to cause pulmonary infections in
immunocompromised patients and lung cancer victims
(Brooke, 2012). It is an obligate aerobe, and along with
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Pseudomonas aeruginosa is known to co-colonize the lungs of
cystic ﬁbrosis sufferers. In the past, the bacterium has been
given a range of names, including P. maltophilia, and as a
‘maltophile’ it has a marked preference for metabolizing
maltose rather than glucose in the growth medium. It is
becoming increasingly recognized as an antibiotic- and
biocide-resistant pathogen which frequently colonizes hospital
catheters and respiratory equipment, forming extensive
bioﬁlms (Deredjian et al., 2016).
The uptake of phosphate anions by bacteria in conditions of
phosphate starvation relies on phosphate-speciﬁc transport
(Pst) proteins which form an ATP-binding cassette (ABC)
transporter. This system includes a water-soluble, periplasmic
binding protein (PstS) with a high afﬁnity for phosphate (Kd ’
0.2 mM; Webb et al., 1992). Bound phosphate groups are
donated to the transmembrane domains of the ABC trans-
porter and hydrolysis of ATP by the intracellular ATP-binding
domain powers the transport of the phosphate anion across
the lipid bilayer against its concentration gradient. PstS acts
as a periplasmic phosphate sensor, which together with the
permease components of the transporter and a range of
intracellular Pho proteins triggers changes in the expression
levels of many genes involved in phosphate metabolism
(Santos-Beneit, 2015). It is interesting that whilst PBPs are
restricted to Gram-negative bacteria, Gram-positive bacteria,
which lack an outer membrane, possess PBP homologues
known as extracytoplasmic binding lipoproteins which are
anchored in the cytoplasmic membrane. The more exposed
nature of these proteins in Gram-positive bacteria means that
they tend to be highly antigenic.
Periplasmic binding proteins (PBPs) constitute a super-
family of proteins which have a two-domain /-fold that is
present in a wide range of protein families, including various
enzymes, receptors and transporter proteins (Felder et al.,
1999). These molecules often lack signiﬁcant sequence iden-
tity, but all adopt a conserved fold and have an underlying
tendency to bind anionic ligands. PBPs exist for the recogni-
tion of monosaccharides and oligosaccharides, amino acids
and polypeptides as well as inorganic nutrients and vitamins.
Thus, PBPs act as the initial receptor for active transport of
these molecules into the cell and are also involved in drug
transport.
The two structural domains of these proteins are connected
by ﬂexible linker regions which act as a hinge, allowing relative
movement of the two domains by as much as 70 to encap-
sulate the bound ligand (Felder et al., 1999). This domain
movement has been likened to a Venus ﬂytrap and plays a
pivotal role in signalling and transport as well as catalysis by
the enzymes which possess this fold. Examples of proteins in
the PBP superfamily include transcriptional regulators such as
the LacI repressor and the extracellular domains of various
neurotransmitter receptors. Many of these proteins are targets
for active drug development and also have biotechnological
applications, for example the familiar maltose-binding protein
(MBP), which is used as an afﬁnity tag in protein expression.
MBP is classed as a type I PBP and like all members of this
class has three crossovers between the two structural domains
of the protein. Each domain of a type I PBP is formed by two
separate segments from the N- and C-terminal halves of the
polypeptide. In contrast, type II PBPs have only two cross-
overs between the domains. This arises by forming domain 1
from the N-terminal and C-terminal portions of the poly-
peptide, while domain 2 is formed exclusively by the middle
segment. Structurally, the domains of both types of PBP
consist of a central -sheet ﬂanked on one or both sides by
-helices. Mutagenesis and structural studies showed that the
residues which interact with the transmembrane components
are only brought close together by the closure of the two
domains upon ligand binding (Martineau et al., 1990; Sharff
et al., 1992). To ensure efﬁcient sensing of the ligand, PBP
molecules are present in much larger numbers than the
transporter or chemotaxis receptors. Therefore, it is particu-
larly important that only the closed, ligand-bound form of the
PBP can activate the transmembrane components. A review of
the structure and function of the PBP superfamily is given by
Berntsson et al. (2010).
Phosphate-binding proteins belong to the type II class of
PBPs and achieve high speciﬁcity by fully dehydrating the
ligand to form a complex in which buried salt bridges and
numerous hydrogen bonds are formed with the buried HPO4
2
(Pi) dianion (Quiocho & Ledvina, 1996). The closely related
bacterial sulfate-binding proteins entrap SO4
2 ions by
hydrogen bonding to the ligand in a similar manner, albeit
without any ionizable residues taking part (Pﬂugrath &
Quiocho, 1985). In the phosphate- and sulfate-binding PBPs,
each O atom of the ligand is involved in multiple hydrogen
bonds to amino acids of the protein, and many involve the
protein main chain. These tight interactions are necessary for
PBPs to distinguish between phosphate and sulfate which,
owing to their marked difference in acid strength, can be
discriminated on the basis of their protonation state. In the
lower speciﬁcity PBPs, such as those which bind sugars, less
intense hydrogen bonding to the ligand, usually involving
protein side chains, is found and aromatic residues also play a
key role in elegant ring-stacking interactions with the hydro-
phobic faces of the sugar (Quiocho & Ledvina, 1996).
The expression of bacterial phosphate-binding proteins is
known to be increased by several orders of magnitude in
phosphate starvation (Fischer et al., 2006; Lewenza et al., 2005;
Madhusudhan et al., 2003). These proteins have been linked
to the virulence of antibiotic-resistant strains and to bioﬁlm
formation, which stems from the formation of large appen-
dages on the bacteria that are rich in secreted phosphate-
binding proteins (Dı´az et al., 2005; Mudrak & Tamayo, 2012;
Neznansky et al., 2014; O’May et al., 2009; Zaborina et al.,
2008).
In the protein crystallization ﬁeld it is sometimes found that
protein impurities, which are present at levels of only a few
percent, crystallize rather than the molecule of interest. Some
examples include the bacterial stress proteins and bacterio-
ferritins (see, for example, van Eerde et al., 2006). Even when
the target protein is afﬁnity-puriﬁed, other molecules which
have inherent afﬁnity for the immobilized ligand can become
concentrated along with the protein of interest, for example
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the histidine-rich sequences of Escherichia coli SlyD and AcrB
cause them to contaminate recombinant His-tagged proteins.
In the case of the membrane protein AcrB, the problem is
compounded by its ability to crystallize when present in
picogram quantities (Psakis et al., 2009). However, in favour-
able cases these crystallization ‘accidents’ have led to new
structures being solved, such as yeast nicotinamidase (Hu et
al., 2005, 2006, 2007) and YcaC from both E. coli (Colovos et
al., 1998) and P. aeruginosa (Grøftehauge et al., 2015). Crys-
tallization contaminants are often only identiﬁed after X-ray
data collection and processing, at which point molecular
replacement with structures that are expected to have
sequence similarity to the target protein proves unsuccessful.
Sometimes the unit-cell dimensions are then found to match
those of a known structure in the PDB and these suspicions
can then be conﬁrmed or refuted ultimately by reﬁnement. In
difﬁcult cases, the molecule may be identiﬁed by dissolving the
crystal and running an SDS–PAGE gel for liquid-chromato-
graphy mass-spectrometric (LC-MS) sequencing of tryptic
peptides. In addition, molecular replacement may be
performed using structures of common crystallization
contaminants; failing this, heavy-atom methods may be the
only option available for solving the structure of the impurity
if its crystallization is reliable. To help to resolve problems of
this sort, the SBGrid service (Stokes-Rees & Sliz, 2010) has
been developed to perform molecular replacement using
Phaser (McCoy et al., 2007) with approximately 100 000
protein domains in the SCOP database (Murzin et al., 1995) as
potential search models.
Here, we report the structure determination of a PstS-like
phosphate-binding protein from S. maltophilia which crystal-
lized unexpectedly during efforts to grow crystals of another
protein. Since the original crystals were no longer available for
LC-MS sequence analysis, the constituent protein was iden-
tiﬁed and solved by a PDB-wide molecular-replacement
search. The structure has been reﬁned to R-factor and Rfree
values of 10.15 and 12.46%, respectively, at 1.1 A˚ resolution.
The structure adopts the type II periplasmic binding protein
fold and possesses a bound phosphate anion in the inter-
domain cleft. We also describe the methodological approaches
needed to process the atomic resolution data with the program
DIALS and to solve the structure efﬁciently by molecular
replacement using all entries in the Protein Data Bank as
potential search models.
2. Methods
2.1. Crystallization
Crystals of the S. maltophilia protein were obtained during
efforts to crystallize the enzyme 2,40-dihydroxyacetophenone
dioxygenase (DAD) from Alcaligenes sp. 4HAP, which had
been expressed in E. coli and puriﬁed as described by Hopper
& Kaderbhai (1999). The freeze-dried protein was dissolved in
deionized water to give a concentration of 2.5 mg ml1, and
crystals which eventually proved to be of the PBP impurity
were obtained by the hanging-drop method in 15%(w/v) PEG
8K, 100 mM Tris–HCl pH 8.0. The droplet consisted of 5 ml
protein solution, 5 ml well solution and 1 ml 100 mM sodium
formate, a product of the reaction catalysed by DAD. A
photomicrograph of the largest crystal, which was obtained
after two years of growth at room temperature, is shown in
Supplementary Fig. S1. The crystals were obtained in only one
crystallization droplet and were transferred using loops to
10 ml of the well solution, to which glycerol was added in four
1 ml droplets to increase the cryoprotectant concentration to
approximately 30%(v/v). The crystals were then mounted
again in loops and ﬂash-cooled in liquid ethane for storage in
liquid nitrogen.
2.2. X-ray data collection
X-ray diffraction data were collected to almost 1.0 A˚
resolution (see Supplementary Fig. S2) using an ADSC Q4r
detector on the ID14-EH2 beamline (Wakatsuki et al., 1998) at
ESRF, Grenoble, France with a ﬁxed wavelength of 0.933 A˚,
some 14 years before completion of the structure analysis. A
high-resolution pass was collected with a crystal-to-detector
distance of 80 mm and, for each diffraction image, the crystal
was rotated slowly through 1 while being exposed to the
beam for 10 s. To record overloaded reﬂections, a low-
resolution pass was then collected with a longer crystal-to-
detector distance of 250 mm and shorter exposures of 1 s
duration for each successive 2 rotation of the goniometer ’
axis.
2.3. Data processing
Initially, the data were integrated withMOSFLM (Battye et
al., 2011) and scaled using SCALA (Evans, 2006) in the CCP4
program suite (Winn et al., 2011) to a resolution of 1.1 A˚. The
scaling statistics and inspection of systematic absences indi-
cated that the space group was P21, with unit-cell parameters
a = 37.7, b = 77.9, c = 56.3 A˚,  = 102.1. Use of the MATT-
PROB server (Kantardjieff & Rupp, 2003) indicated that
there were likely to be two molecules of DAD (which are
approximately 20 kDa each) in the asymmetric unit. However,
attempts at molecular replacement with various search models
which had sequence homology to DAD failed to yield a
solution, and when the structure of DAD was solved in a
different crystal form (Beaven et al., 2014; Keegan et al., 2014)
this also did not provide a convincing solution with the 1.1 A˚
resolution data set.
2.4. Data reprocessing
We then felt it necessary to check the original data
processing in case any complications such as crystal twinning
or incorrect space-group assignment had occurred. To repro-
cess the original diffraction images collected some 14 years
prior, the data were read from DLT4 tape by Advanced
Downloading Ltd, Putney, London, England. The high- and
low-resolution passes were processed separately by xia2
(Winter, 2010), running the DIALS (Waterman et al., 2013)
pipeline, as available in CCP4 v.7.0. Spot-ﬁnding in DIALS is
based on the method used by XDS (Kabsch, 2010), in which a
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series of ﬁlters are applied to the images, resulting in a binary
threshold map which identiﬁes the strong pixels that may be
part of a spot. Since the default spot-ﬁnding parameters in
DIALS are currently optimized for Pilatus detectors, rather
than CCDs, some optimization was required to reduce noise
and spurious artefacts in the strong-spot list. This was under-
taken interactively using dials.image_viewer (Supplementary
Fig. S3) and the improved parameters were passed to
dials.ﬁnd_spots using the command-line options kernel_
size=2,2, sigma_background=10 and sigma_strong=10. In
addition, to index the high-resolution pass correctly it was
necessary to provide the known unit cell as a hint using the
option unit_cell=37.8,56.4,78.0,90,90,102. Successful
processing was also found to be possible by correcting the
poor initial diffraction geometry using dials.discover_better_
experimental_model followed by dials.index. In retrospect, we
found that the beam centre in the image headers was wrong by
approximately 1 mm, causing one of the unit-cell parameters
to become doubled, and the use of dials.check_indexing_
symmetry showed that the supposed beam centre for this
solution was located at the (0, 1, 0) reﬂection.
The programs dials.reﬁne_bravais_settings and dials.reindex
were used to apply monoclinic constraints in the conventional
setting and further geometry reﬁnement was performed with
dials.reﬁne, ﬁtting ﬁrst a static model of the crystal followed by
a scan-varying model (Waterman et al., 2016). Integration of
the images was perfomed by dials.integrate with default
parameters, and subsequent scaling and merging of the
intensity data was undertaken using AIMLESS (Evans, 2006;
Evans & Murshudov, 2013).
2.5. Molecular replacement using the entire PDB
Initial attempts at molecular replacement (MR) with the
reprocessed data set were performed using the previously
solved DAD structure (PDB entry 4p9g), as before. Several
search models derived from PDB entry 4p9g and its closest
homologues were used, but none yielded any indication of
possible success. Hence, it was concluded that this crystal
probably did not contain what we expected. We next used the
AMPLE (Bibby et al., 2012) and ARCIMBOLDO (Rodrı´guez
et al., 2009) programs from the CCP4 suite to try and position
fragment models such as helices using molecular replacement.
With the high-resolution data even a small fragment correctly
positioned should be enough of a ‘seed’ for the SHELXE
(Sheldrick, 2010) density modiﬁcation and C-tracing algo-
rithm to potentially build up a more complete backbone of the
target structure. However, all attempts at this failed, which
may be a consequence of the relatively large unit cell and the
lack of a heavier-than-average atom to ‘seed’ the ab initio
phasing. We then speculated that it was a contaminant protein
that may have already been solved and deposited in the PDB,
as for example reported by Benini et al. (2004). With this
hypothesis, we searched for known structures with similar
unit-cell dimensions using the nearest-cell server (Ramraj et
al., 2012). However, this did not generate any candidates,
suggesting that a more comprehensive approach was needed.
Finally, we considered performing MR using search models
from all of the available PDB structures. To limit the
computational overhead, we decided to invoke a quick rota-
tion and translation search using MOLREP (Vagin &
Teplyakov, 2010) with the resolution of the data limited to
3.0 A˚. We also limited the number of top rotation-function
(RF) peaks [as scored by RF/(RF)] that were sampled in the
translation function to ﬁve. This gave us the advantage of
being able to sample a large subset of the entire PDB rela-
tively quickly using a multi-core cluster. We used a simple
script that only sampled the ﬁrst chain from each of the
approximately 116 000 known PDB structures (at the time of
running). In addition, to further speed up calculations only
one copy of the model was searched for. No discrimination
was made on the type of search model (DNA, RNA etc.) or
on size or similarity to others in the PDB. This potentially
resulted in a lot of unnecessary tests being performed, but with
each MOLREP job running for an average of 38 s the effort
required to eliminate any redundancy would have taken
longer than to run the entire test. To complete the search took
20 h on the 60 cores of the CCP4 cluster.
When the test had completed, the log ﬁles indicated that
several search models had clearly deﬁned strong and
outstanding peaks in the rotation search. The rotation search
lacks the sensitivity of the translation search, but has the
advantage of being independent of packing constraints and
screw-axis assignment, so for this coarse-grained approach
using unmodiﬁed search models it was deemed to be a more
reliable indicator of success. The best-scoring search models
were chain A from each of PDB entries 4f1u and its related
structures 4f1v, 4f19, 4f18 and 2q9t, which are all high-
resolution structures of phosphate-binding proteins. For
example, with chainA of PDB entry 2q9t (Ahn et al., 2007) the
rotation function had a signal-to-noise ratio of 13.16 (which
compared favourably with the highest noise peak of 4.92) and
the corresponding translation function had a signal-to-noise
ratio of 8.63 (which again compared well with the highest
noise peak in the list of 2.99).
Further validation of the solution was carried out by
molecular replacement with Phaser (McCoy et al., 2007) using
chain A of PDB entry 2q9t as a search model. It produced a
single solution with a translation-function Z-score of 13.7 and
a log-likelihood gain of 286 after rigid-body reﬁnement.
The positioned model was then subjected to ten cycles of
restrained reﬁnement in REFMAC5 (Murshudov et al., 1997,
2011), giving a ﬁnal R and Rfree of 0.43 and 0.45, respectively.
Visual examination of the resulting electron-density map in
Coot (Emsley & Cowtan, 2004; Emsley et al., 2010) showed a
clear correlation between the model and the electron density,
with strong difference map peaks that suggested improve-
ments to the model (Supplementary Fig. S4). The unknown
structure was later found to have a sequence identity of 44%
and an r.m.s.d. of 1.3 A˚ to PDB entry 2q9t.
At this point it was clear that chain A of PDB entry 2q9t
provided a good approximation for the phases of the unknown
structure, but model building and completion would still
present a problem owing to the lack of sequence information.
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However, with data extending to 1.1 A˚ resolution, it was found
that most of the side chains could be identiﬁed correctly by
density modiﬁcation using SHELXE (Sheldrick, 2010). This
program generated a model of the protein main chain which
included 338 residues (out of a ﬁnal total of 373) and had a
correlation coefﬁcient to the data of 40.35%. Reﬁning this
backbone model against the data produced a difference map
that gave clear density for many of the side chains. Using Coot,
we initially added the larger, more obvious side chains such as
Trp, Tyr and His. Further reﬁnement of the improved model
allowed more of the side chains to be added and the addition
of the missing residues. This reﬁnement and manual building
procedure was cycled through until much of the model was
complete, and a round of automatic rebuilding with ARP/
wARP (Langer et al., 2008) was then undertaken.
At this stage, some ambiguity in the sequence remained
(e.g.Asp/Asn, Glu/Gln and Val/Thr) but it was correct enough
to provide a good approximation to the target sequence. A
BLAST search then indicated that the closest known sequence
was that of a PstS-like protein from S. maltophilia strains
R551-3 (UniProt ID B4SL31) or RA8 (UniProt ID M5D7J9),
which have identical amino-acid sequence. Further inspection
of the electron density showed that the sequence of this
protein ﬁtted the atomic resolution map extremely well and
indicated how improvements could be made to the model.
High sequence identity was found with a range of PBPs from
other strains of S. maltophilia, but efforts to build in the
sequence of at least one close homologue quickly stalled
owing to poor ﬁt to the density. Subsequent rebuilding of the
completed model using Coot and reﬁnement with REFMAC,
SHELX (Sheldrick & Schneider, 1997; Sheldrick, 2011) and
PHENIX (Adams et al., 2010) was undertaken using default
geometric restraints with each program. The structure was
reﬁned with anisotropic B factors, riding H atoms and 15 dual-
occupancy side-chain groups. Figures of the structure were
prepared using CueMol (http://www.cuemol.org/en) and the
sequence alignment was prepared using ALSCRIPT (Barton,
1993). Bioinformatic analysis was performed using ExPASy
(Gasteiger et al., 2003), UniProt (2015) and KEGG (Kanehisa
et al., 2016). The structure and reﬂection data have been
deposited in the Protein Data Bank (http://www.wwpdb.org)
with accession code 5jk4. The original diffraction images are
openly accessible at the DOI 10.5281/zenodo.49859.
For proteomic analyses, gel samples were reduced, carba-
midomethylated and digested with trypsin using a standard
protocol (Abdul-Salam et al., 2006). Peptides were analysed
using a LTQ-Velos mass spectrometer (Thermo Fisher
Scientiﬁc) coupled to a nanoACQUITY UPLC (Waters) and
were identiﬁed using the Mascot search engine (Matrix
Science, London, England; http://www.matrixscience.com).
3. Results
The predicted molecular weight of the S. maltophilia phos-
phate-binding protein (38 338 Da) is consistent with at least
one faint band visible on SDS–PAGE analysis of the original
freeze-dried, puriﬁed DAD sample (see Supplementary Fig.
S5), which initially suggested that the protein which crystal-
lized may have originated from contamination by S. malto-
philia during expression or puriﬁcation. However, LC-MS
sequencing of the proteins of this molecular weight which
were present in the SDS–PAGE gel established that they were
most likely of E. coli origin (Supplementary Table S1), indi-
cating instead that S. maltophilia may have grown in the
crystallization droplet and produced the phosphate-binding
protein, which crystallized there.
3.1. Three-dimensional structure
Reﬁnement of the S. maltophilia phosphate-binding protein
structure at 1.1 A˚ resolution decreased the R factor and Rfree
to 10.15 and 12.46%, respectively. The reﬁnement and other
statistics are shown in Table 1, where it can be seen that the
overall data completeness (94%) is perhaps slightly lower than
would be desired. However, the situation is better at lower
resolution: for example, the overall completeness increases to
96% at 1.3 A˚ and to 98% at 1.7 A˚. Since this effect probably
stems from the low symmetry of the crystal and the fact that
the data were collected in a single pass, improving the
completeness would require the collection of data from a re-
oriented crystal. However, the expected difﬁculties in repro-
ducing the crystallization of an impurity and the length of time
required to obtain the original crystals (two years) suggested
that it was better to focus on the available data set, which
appeared to be of high quality by most other criteria. In
addition, the electron density for the molecule was found to be
research papers
Acta Cryst. (2016). D72, 933–943 Keegan et al.  Periplasmic phosphate-binding protein 937
Table 1
X-ray data-collection, processing and reﬁnement statistics.
Values in parentheses are for the outer resolution shell.
Beamline ID14-EH2
Wavelength (A˚) 0.933
Space group P21
Unit-cell parameters
a (A˚) 37.73
b (A˚) 77.86
c (A˚) 56.29
 () 102.08
Solvent content (%) 41.7
No. of molecules per asymmetric unit 1
Matthews coefﬁcient (A˚3 Da1) 2.1
Mosaic spread () 0.44
Resolution (A˚) 44.94–1.10 (1.12–1.10)
Completeness (%) 94.1 (85.9)
Rmerge† (%) 7.6 (63.1)
Rmeas‡ (%) 8.5 (73.8)
CC1/2§ (%) 99.8 (70.8)
Average I/(I) 9.7 (2.3)
Multiplicity 4.4 (3.7)
No. of observed reﬂections 533955 (20147)
No. of unique reﬂections 120995 (5469)
Wilson plot B factor (A˚2) 5.3
R factor (%) 10.15
Free R factor (%) 12.46
No. of reﬂections in test set 5935
R.m.s.d., bond lengths (A˚) 0.006
R.m.s.d., bond angles () 0.961
Mean protein B factor (A˚2) 9.9
† Rmerge =
P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ. ‡ Rmeas =
P
hklfNðhklÞ=
½NðhklÞ  1g1=2Pi jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ. § Half-set correlation coefﬁ-
cient (Karplus & Diederichs, 2012).
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extremely well deﬁned throughout its length, with only half a
dozen of the longer side chains being poorly deﬁned out of 373
amino acids. According to theMolProbity criteria (Chen et al.,
2010), 98.4% of all residues in the model are in ‘favoured’
regions of the Ramachandran plot and all residues have
‘allowed’ main-chain conformations.
Given that the protein has been identiﬁed by ‘visual’ X-ray
sequencing, it is possible that the poorly ﬁtting side chains may
actually be different amino acids. However, replacing these
residues with those that appear to ﬁt the electron density
better and repeating the BLAST search still indicates that this
molecule is most likely to be the S. maltophilia PstS-like
protein. This suggests that the initial identiﬁcation is correct
and that any possible deviation from this sequence is most
likely owing to natural variation within this bacterial species.
The overall structure is shown in Fig. 1 and, as an example
of the map quality, Fig. 2 shows the N-terminal glutamine. This
residue has very clearly undergone a cyclization reaction to
form pyroglutamate, a condensation product which commonly
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Figure 1
The tertiary structure of the S. maltophilia phosphate-binding protein.
The secondary-structure elements are numbered to emphasize the
topological twofold symmetry that exists between domains 1 (bottom)
and 2 (top), with the domain number of each element indicated by the
subscript. The phosphate group is drawn in the centre of the structure in
ball-and-stick representation with the P atom coloured purple. The N-
and C-termini are labelled at the bottom.
Figure 2
A sample of the 2Fo  Fc electron density for the S. maltophilia
phosphate-binding protein at 1.1 A˚ resolution. The N-terminal pyro-
glutamate residue (formed from glutamine) is shown at the bottom centre
and the symmetry-related molecule with which it interacts is shown at the
upper left (residue numbers indicated by primes). The electron density is
contoured at 2.0 r.m.s.
Figure 3
The topology of the S. maltophilia phosphate-binding protein. The
numbers for residues forming each of the secondary-structure elements
are shown at the termini of each strand and helix. The general position of
the phosphate anion between domains 1 and 2 is indicated as ‘Pi’ and the
helix dipoles which interact with it are shown as pale grey dashed lines.
Note that the secondary-structure elements and loop regions are not
drawn to scale and that some loops are particularly extended, for example
the region between 42 and 51 is almost 50 residues in length.
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occurs in proteins possessing N-terminal Glu or Gln residues.
In this case, the N-terminal glutamine is generated by cleavage
of the N-terminal signal peptide, which is 24 amino acids in
length.
The topology is shown in Fig. 3, where the secondary-
structure elements of this PBP superfamily member are
numbered according to their positions within each of the
domains. The general position of the phosphate anion bound
between domains 1 and 2 is indicated and it can be seen that
the N-termini of four -helices (11, 21, 12 and 22) are
oriented towards it. The involvement of these helix dipoles is
believed to be a major factor in the afﬁnity of anion-binding
PBPs for their ligands (He & Quiocho, 1993).
Given that only around 200 amino acids are required to
form the essential type II PBP fold (shown in Fig. 3), the fact
that the S. maltophilia protein is almost twice this length
emphasizes that it has a number of substantial elaborations on
the core structure shown. These mainly occur in the form of
very extended loops, such as the region connecting 52 to 12,
which includes a section of -helix from residues 114 to 121
(02). This helix contains the residue Cys118 which forms a
disulﬁde bridge to Cys163 in helix 12. Another very extended
loop region is that which crosses over from domain 2 to
domain 1 by connecting 42 to 51. In addition, there is a
curious projecting -hairpin formed by 12 residues that are
inserted in between helices 41 and 51, and towards the
C-terminal end of the protein there is an extra -helix 61
which runs antiparallel to 41. The ﬁnal 20 residues at the
C-terminal end of the protein form a largely irregular but very
well deﬁned region which in three dimensions appears to slot
between strands 41 and 51. Here, Cys366, which is in the
C-terminal irregular region, forms a disulﬁde bridge to Cys296
that immediately follows 51.
In general, PBPs contain a region of -helix in the
connection between 32 and 42 which maintains the topo-
logical twofold symmetry relating domains 1 and 2. However,
this helix in domain 2, which would be topologically equiva-
lent to 31 in domain 1, is not present in the S. maltophilia
protein and is replaced by an irregular loop region. In the
other loops, there are several additional short helical regions
which have a mixture of 310-helical and -helical character at
positions 127–131, 164–169, 188–192, 250–257, 262–272 and
362–367. Although some of the secondary-structure elements
shown in Fig. 3 are reduced to being 2–3 residues in length in
both domains of the protein, it appears that domain 1 adheres
more strongly to the archetypal type II PBP fold than domain
2 does.
A sequence alignment of the S. maltophilia phosphate-
binding protein with two related molecules from different
bacteria is shown in Fig. 4. The second sequence shown has
approximately 51% sequence identity and is a putative
secreted alkaline phosphatase from P. aeruginosa (LapA; Ball
et al., 2002). However, the structure of the S. maltophilia
protein does not reveal any bound metal ions, which are
usually essential for alkaline phosphatase activity, suggesting
that the P. aeruginosa molecule is also a phosphate-binding
protein. The S. maltophilia protein has 44% sequence identity
to its counterpart in P. ﬂuorescens (Elias et al., 2012) but only
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Figure 4
A sequence alignment of the S. maltophilia protein with two similar bacterial phosphate-binding proteins. The amino acids are coloured according to the
following scheme: acidic, red; basic, pale blue; neutral polar, green; hydrophobic, purple; cysteine, yellow; the structurally important residues Gly, Ala
and Pro, white. The residues which interact directly with the phosphate are boxed and the disulﬁde pairing of the four invariant cysteines is indicated by
the symbols * and + below. The secondary-structure elements of the protein are labelled and displayed with a similar colour scheme to that in Figs. 1
and 3.
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around 28% identity to the more distantly related E. coli
protein (Wang et al., 1997; not shown). At 321 residues, the
E. coli protein is somewhat shorter than the PBPs from
S. maltophilia and P. ﬂuorescens, which consist of 373 and 371
amino acids, respectively. These two proteins also have
signiﬁcant homology to the cDNA sequence of a reported
human phosphate-binding protein (DING), although the gene
for this protein does not appear to be present in the human
genome (Morales et al., 2006; Berthier, 2013), possibly
suggesting that it might instead be of bacterial origin, as
corroborated by codon-usage analysis (Lewis & Crowther,
2005). PstS from Clostridium perfringens has recently been
analysed (Gonzalez et al., 2014) and at 246 amino acids it is
signiﬁcantly shorter than even the E. coli protein. Structures
are available for PstS from a range of bacteria, including
P. aeruginosa (Neznansky et al., 2014; 299 residues), Yersinia
pestis (Tanabe et al., 2007; 321 residues), Vibrio cholerae (PDB
entry 1twy; 253 residues; New York SGX Research Center for
Structural Genomics, unpublished work), Lactobacillus brevis
(PDB entry 4ecf; 262 residues; Joint Center for Structural
Genomics, unpublished work), Mycobacterium tuberculosis
(Ferraris et al., 2014; 348 residues), Borreliella burgdorferi
(Brautigam et al., 2014; 265 residues) and Streptococcus
pneumoniae (PDB entries 4exl and 4lat; 274 residues; Center
for Structural Genomics of Infectious Diseases, unpublished
work). Overall, the sequence of the S. maltophilia PstS-like
protein aligns quite poorly with its counterparts in these other
organisms, although the sequence identity rises signiﬁcantly
above 30% in local regions corresponding to the main
secondary-structure elements.
The structure of the S. maltophilia PBP superimposes on the
P. ﬂuorescens protein with an r.m.s.d. of 1.3 A˚ for 335 struc-
turally equivalent residues (Fig. 5). The notably high value of
this r.m.s.d. in spite of the reasonably high sequence identity of
these two proteins (44%) could in principle be a reﬂection of
either domain movement or large local structural differences
between these two ligand-bound PBPs. The two structures
diverge signiﬁcantly in the following regions of the S. malto-
philia protein: 17–32, 50–55, 78–84, 165–179, 192–198, 203–205,
228–230, 248–264 and 353–355. In addition, the P. ﬂuorescens
protein has quite large insertions between residues 242 and
243 and between residues 277 and 278 of the S. maltophilia
sequence. Conversely, the loop region between residues 317
and 326 of the S. maltophilia protein is absent in P. ﬂuorescens
PstS. Since domains 1 and 2 appears to be oriented almost
identically in both structures, the local differences, which are
apparent in Fig. 5, are likely to be the dominant factor
contributing to the high r.m.s.d.
3.2. Phosphate-binding site
Very close to the N-terminal end of the protein, the loop
linking strand 11 and helix 11 plays an important role in
binding the phosphate anion. The main-chain amide N atom
and the side-chain hydroxyl group of Ser10 form hydrogen
bonds to the O1 atom of the phosphate group. In addition, the
main-chain amide of the next residue in the chain (Leu11)
donates a hydrogen bond to the O4 atom of the phosphate.
These residues lie at the N-terminal end of helix 11, where
the helix dipole most likely stabilizes the negative charge on
the phosphate group. The next residue to interact with the
phosphate is Ser35, the amide and hydroxyl groups of which
both hydrogen-bond to the O3 atom of the ligand. This serine
residue lies at the N-terminal end of helix 21. Further along
the chain, the carboxyl group of Asp62 appears to interact
very strongly with O4 of the phosphate by forming a short
hydrogen bond to it. This has a donor-to-acceptor atom
distance of 2.5 A˚, which is within the range of a low-barrier
hydrogen bond (Cleland et al., 1998), suggesting that the
proton between these two groups is shared to a greater extent
than in a normal hydrogen bond. Full-matrix inversion with
SHELX (Sheldrick & Schneider, 1997) following reﬁnement
using all reﬂections indicates that the standard deviations of
the bond lengths in the binding site are in the region of 0.01 A˚,
suggesting that the structure has been determined with high
accuracy and that the shortness of this hydrogen bond is likely
to be a real effect. Another unusual feature of this aspartate is
that its side chain adopts a rather unfavourable conformation
in which the C—C bond is almost fully eclipsed with the
main-chain N—C bond, suggesting that a strain mechanism
may be involved in phosphate binding and release.
The next residue of the polypeptide to interact with the
phosphate is the guanidinium group of Arg145 in domain 2.
This residue forms charge-assisted hydrogen bonds to O1 and
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Figure 5
A superposition of the S. maltophilia phosphate-binding protein with the
successful search model from P. ﬂuorescens (PDB entry 2q9t). The
molecules are in approximately the same orientation as in Fig. 1 and are
coloured green for S. maltophilia and yellow for P. ﬂuorescens, with the
phosphate groups for both shown in ball-and-stick representation.
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O2 of the phosphate. Arg145 lies in the loop linking strand 12
and the N-terminal end of helix 12, which is the next region of
the protein to interact intensively with the phosphate group.
Here, various main-chain amide and side-chain hydroxyl
groups of the tripeptide Ser-Gly-Thr (residues 149–151) form
a total of four hydrogen bonds to O2 and O3 of the phosphate
(for full details, see Table 2 and Fig. 6). In total, O2 accepts
four hydrogen bonds from donor groups in the protein, O1
and O3 both accept three and O4 appears to form only two
hydrogen bonds. Interestingly, one of these involves the only
carboxyl side chain in the binding site, that of Asp62, which is
likely to be deprotonated at the pH of crystallization, espe-
cially in such close proximity to the phosphate group which is
likely to be in the dianionic form. Thus, it is probable that this
aspartate accepts a hydrogen bond from the single proton of
the bound HPO4
2 and this appears to be a low-barrier
hydrogen bond (see above), suggesting that the proton is
shared equally by both groups rather than being localized
preferentially on one of them. The short strong hydrogen
bond presumably stabilizes the unfavourable side-chain
conformation of Asp62. Interestingly, this residue is thought to
be the basis for the speciﬁcity of PstS proteins for phosphate
relative to sulfate anions. Owing to its lack of a proton at
physiological pH, sulfate would be unable to hydrogen-bond
to the aspartate side chain. Conversely, the speciﬁcity of
sulfate-binding proteins is thought to stem from their lack of
charged residues at the binding site and the fact that none of
the groups contacting the ligand would be able to accept a
hydrogen bond from a phosphate anion. The complete dehy-
dration of the ligand upon binding is clearly important to
achieve this sort of speciﬁcity (Quiocho & Ledvina, 1996)
The residues forming the phosphate-binding site are
strongly conserved. For example, in the E. coli and P. ﬂuor-
escens proteins all of the above hydrogen-bonding side chains
are conserved, with the exception of Ser10, which is replaced
by a functionally analogous threonine in the other two species.
Interestingly, a glycine residue at the N-terminal end of helix
22, Gly207, is replaced by larger, polar side chain in the other
organisms. This helix has its dipole oriented towards the
phosphate-binding site but is at a greater distance than the
other helices mentioned above and is likely to play a less
important role in ligand binding. Gly207 is replaced by
asparagine in E. coli and serine in P. ﬂuorescens, the polar side
chains of which are oriented towards the phosphate, although
neither interact with it by hydrogen bonding. A number of
water molecules occupy the pocket between Gly207 and the
phosphate; indeed, these are the water molecules which come
closest to the otherwise fully dehydrated phosphate.
4. Discussion
We have determined the structure of a periplasmic phosphate-
binding protein from S. maltophilia as a result of it crystal-
lizing unexpectedly as an impurity following the expression
and puriﬁcation of a completely unrelated protein. Others
have reported the unexpected crystallization of phosphate-
binding proteins (Morales et al., 2006; Diemer et al., 2008; Gai
et al., 2013), which we suggest is most likely to arise from the
contamination of expression, puriﬁcation or crystallization
media by antibiotic-resistant bacteria, or possibly also from
accidental incorporation of DNA encoding a bacterial PBP
into the expression vector during the gene-cloning stages.
In our structural studies, a PDB-wide molecular-replacement
search followed by reﬁnement at atomic resolution allowed
the unambiguous identiﬁcation of the crystallization impurity
reported here as a PstS-like protein from S. maltophilia. The
sequence determined from the atomic resolution X-ray data
indicate that it originates from either the R551-3 or the RA8
strain of S. maltophilia. Interestingly, the R551-3 strain is the
second most common endophytic (i.e. plant-endosymbiotic)
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Table 2
Hydrogen bonds at the phosphate-binding site.
In all cases the reﬁnement e.s.d. for the donor-to-acceptor atom distance is
0.01 A˚.
Hydrogen-bonded atom pairs Donor–acceptor distance (A˚)
Ser10 N  Pi O1 2.81
Ser10 O  Pi O1 2.69
Leu11 N  Pi O4 3.04
Ser35 N  Pi O3 2.76
Ser35 O  Pi O3 2.69
Asp62 O1  Pi O4 2.51
Arg145 N1  Pi O2 2.83
Arg145 N2  Pi O1 2.81
Ser149 O  Pi O2 2.71
Gly150 N  Pi O3 2.79
Thr151 N  Pi O2 3.03
Thr151 O1  Pi O2 2.68
Figure 6
The phosphate-binding site. Residues forming hydrogen bonds to the
phosphate anion are shown along with the 2Fo  Fc electron density
contoured at 5.0 r.m.s. The P atom is coloured purple and the numbers of
the phosphate O atoms, corresponding to the text, are shown. The
phosphate hydrogen bonds are drawn as dashed lines. Note the
unfavourable side-chain conformation of Asp62, which forms a low-
barrier hydrogen bond to O4 of the phosphate. Further details of the
phosphate hydrogen bonds are given in Table 2.
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bacterium in the poplar tree Populus trichocarpa (Ryan et al.,
2009), suggesting that our structural studies may have agro-
nomic application. In contrast, the RA8 strain was isolated
from a sewage-treatment works in Karlsruhe (Adamek et al.,
2014). However, since the protein from these isolates has in
excess of 90% sequence identity to those produced by human
pathogenic strains, our structure is an excellent model of the
protein from disease-causing strains of S. maltophilia.
Several studies have suggested that phosphate-binding
proteins have an ultrastructural role in bacterial adhesion and
bioﬁlm stability as well as in phosphate scavenging (see, for
example, Zaborina et al., 2008). Accordingly, at the genetic
level, the protein we have analysed has suggestive differences
from the archetypal PstS protein, the gene for which resides in
an operon together with genes for the associated transmem-
brane transporter components. In contrast, the coding region
for the phosphate-binding PBP reported here lies adjacent to
the gene for another PBP with 47% identity and both are
within a cluster of genes for components of a type II secretion
system, as also reported for P. aeruginosa (Ball et al., 2002).
Given that the closest homologue of known structure
(P. ﬂuorescens) only has 44% sequence identity, the high
resolution of the X-ray data set that we have obtained from
the S. maltophilia protein has no doubt aided greatly in the
structure analysis. The 1.1 A˚ resolution data have also allowed
the deﬁnition of unusual features such as the pyroglutamate
residue which is formed by cyclization of the N-terminal
glutamine and the presence of a low-barrier hydrogen bond
between Asp62 and the bound phosphate. Overall, the protein
adopts the type II PBP fold with many extensive elaborations
on the core topology, which is conserved in many protein
families. The role of these elaborations remains to be deter-
mined, but it is possible that they allow interactions with other
bacterial proteins involved in transport and bioﬁlm formation.
The phosphate anion is bound in between the two domains of
the protein and is fully dehydrated in the complex, which
involves many conserved hydrogen bonds and dipole inter-
actions at the N-termini of several helical segments. The
structure corroborates previous suggestions that the aspartate
and arginine residues which interact with the bound anion
(Asp62 and Arg145) play key roles in allowing the protein to
discriminate phosphate from sulfate.
Since the use of PstS as a vaccine has been explored at the
protein and DNA levels (see, for example, Tanghe et al., 1999;
Vyas et al., 2003), knowledge of the structure of S. maltophilia
PstS-like protein, and in particular its exposed, irregular and
most likely highly antigenic regions, may now potentially
facilitate vaccine design targeting this pathogen. In addition,
knowledge of the three-dimensional structure of this protein
will assist in deﬁning its possible role in virulence and bioﬁlm
formation by multidrug-resistant pathogens, potentially with
therapeutic applications.
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